CAN-med Healthcare Announces New Partnerships
CAN-med Healthcare, a division of IMP Group Limited, proudly announces that they have obtained three new and exclusive distribution agreements within CAN-med Healthcare’s Medical/Surgical business unit.
These agreements and new manufacturer partnerships represent a growth opportunity for the organization that is supportive of, and aligned with, the goals and objectives of the Company’s strategic plan.
CAN-med Healthcare has made, and will continue to make, a substantial investment in the area of people resources as they begin to sell and promote these new products from coast to coast.
The manufacturers with which CAN-med Healthcare has established these new partnerships are:
Sanuwave: Manufacturers of dermaPACE, a device designed to treat chronic wounds using ultrasound technology. Initial research points to success in the care of diabetic foot ulcers, but the product can be used to treat all wounds that do not heal through normal clinical methods. www.sanuwave.com
Guided Therapeutics: Manufacturers of LuViva, a cervical cancer screening device that is painless and can detect cancer up to two years earlier than a PAP or biopsy. It delivers a report on the spot, saving the healthcare system both time and money, and the patient the anxiety of waiting for results. www.guidedinc.com
Katalyst: Is an innovative manufacturer of high quality titanium microsurgical instruments. This company’s products are presently focused on the eye surgery market, and plans to release a line of neurosurgical instruments for brain surgery before year end. www.katalystsurgical.com
CAN-med Healthcare recognizes Jim Ritcey, Director, Marketing & Sales – Medical/Surgical, for his tremendous effort in signing agreements with these new strategic partners.